Mass Spectrometry-Based Identification of MHC-Associated Peptides

被引:27
|
作者
Kote, Sachin [1 ]
Pirog, Artur [1 ]
Bedran, Georges [1 ]
Alfaro, Javier [1 ]
Dapic, Irena [1 ]
机构
[1] Univ Gdansk, Int Ctr Canc Vaccine Sci, PL-80308 Gdansk, Poland
关键词
Neoantigens; mild acid elution; immunoprecipitation; mass spectrometry; cancer; CLASS-I; ANTIGEN PRESENTATION; PRESENTED PEPTIDES; VIABLE CELLS; GENERATION; DISCOVERY; IMMUNOPEPTIDOMICS; FRAGMENTATION; QUANTITATION; REPERTOIRE;
D O I
10.3390/cancers12030535
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neoantigen-based immunotherapies promise to improve patient outcomes over the current standard of care. However, detecting these cancer-specific antigens is one of the significant challenges in the field of mass spectrometry. Even though the first sequencing of the immunopeptides was done decades ago, today there is still a diversity of the protocols used for neoantigen isolation from the cell surface. This heterogeneity makes it difficult to compare results between the laboratories and the studies. Isolation of the neoantigens from the cell surface is usually done by mild acid elution (MAE) or immunoprecipitation (IP) protocol. However, limited amounts of the neoantigens present on the cell surface impose a challenge and require instrumentation with enough sensitivity and accuracy for their detection. Detecting these neopeptides from small amounts of available patient tissue limits the scope of most of the studies to cell cultures. Here, we summarize protocols for the extraction and identification of the major histocompatibility complex (MHC) class I and II peptides. We aimed to evaluate existing methods in terms of the appropriateness of the isolation procedure, as well as instrumental parameters used for neoantigen detection. We also focus on the amount of the material used in the protocols as the critical factor to consider when analyzing neoantigens. Beyond experimental aspects, there are numerous readily available proteomics suits/tools applicable for neoantigen discovery; however, experimental validation is still necessary for neoantigen characterization.
引用
收藏
页数:14
相关论文
共 50 条
  • [11] A mass spectrometry-based method to screen for a-amidated peptides
    An, Zhenming
    Chen, Yudan
    Koomen, John M.
    Merkler, David J.
    PROTEOMICS, 2012, 12 (02) : 173 - 182
  • [12] MHC-associated peptides differentially modulate superantigen presentation to T cells
    Broussard, DR
    Wen, R
    Surman, S
    Hogg, TL
    Baker, M
    Collins, C
    Woodland, DL
    FASEB JOURNAL, 1998, 12 (05): : A1086 - A1086
  • [13] Peptides in the Brain: Mass Spectrometry-Based Measurement Approaches and Challenges
    Li, Lingjun
    Sweedler, Jonathan V.
    ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, 2008, 1 : 451 - 483
  • [14] Theoretical Assessment of Indistinguishable Peptides in Mass Spectrometry-Based Proteomics
    Elhamraoui, Zahra
    Borras, Eva
    Wilhelm, Mathias
    Sabido, Eduard
    ANALYTICAL CHEMISTRY, 2024, 96 (40) : 15829 - 15833
  • [15] Analysis of food proteins and peptides by mass spectrometry-based techniques
    Mamone, Gianfranco
    Picariello, Gianluca
    Caira, Simonetta
    Addeo, Francesco
    Ferranti, Pasquale
    JOURNAL OF CHROMATOGRAPHY A, 2009, 1216 (43) : 7130 - 7142
  • [16] Mass Spectrometry-Based Fragmentation as an Identification Tool in Lignomics
    Morreel, Kris
    Kim, Hoon
    Lu, Fachuang
    Dima, Oana
    Akiyama, Takuya
    Vanholme, Ruben
    Niculaes, Claudiu
    Goeminne, Geert
    Inze, Dirk
    Messens, Eric
    Ralph, John
    Boerjan, Wout
    ANALYTICAL CHEMISTRY, 2010, 82 (19) : 8095 - 8105
  • [17] Mass Spectrometry-Based Intraoperative Tissue Identification in Neurosurgery
    Neidert, Marian Christoph
    Bozinov, Oliver
    WORLD NEUROSURGERY, 2013, 80 (06) : 683 - 684
  • [18] Electrospray mass spectrometry for the identification of MHC class I-associated peptides expressed on cancer cells
    Bonner, PLR
    Lill, JR
    Hill, S
    Creaser, CS
    Rees, RC
    JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 262 (1-2) : 5 - 19
  • [19] Sample Preparation for Mass Spectrometry-Based Proteomics; from Proteomes to Peptides
    Rogers, John C.
    Bomgarden, Ryan D.
    MODERN PROTEOMICS - SAMPLE PREPARATION, ANALYSIS AND PRACTICAL APPLICATIONS, 2016, 919 : 43 - 62
  • [20] Susceptibility to transglutaminase of gliadin peptides predicted by a mass spectrometry-based assay
    Mamone, G
    Ferranti, P
    Melck, D
    Tafuro, F
    Longobardo, L
    Chianese, L
    Addeo, F
    FEBS LETTERS, 2004, 562 (1-3) : 177 - 182